Relmada Therapeutics Inc (NAS:RLMD)
$ 2.77 -0.03 (-1.07%) Market Cap: 83.58 Mil Enterprise Value: 13.14 Mil PE Ratio: 0 PB Ratio: 1.36 GF Score: 40/100

Relmada Therapeutics Inc (RLMD) Transcripts

  • 1